Scaling back treatment for three kinds of cancer can make life easier for patients without compromising outcomes, doctors reported at the world's largest cancer conference.
Jun 2, 2024
1
99
Researchers conducting an international study of more than 11,000 ovarian cancer cases have found that selected ovarian cancer risk factors vary for women of different racial and ethnic backgrounds.
May 31, 2024
0
0
Early detection improves treatment outcomes for endometrial and ovarian cancers, yet far too often women are diagnosed in advanced stages of these diseases. Unlike many other cancers, there are no standard screenings for ...
May 30, 2024
0
0
Monique Gary, a breast cancer surgeon, is a self-described "Philly girl" who was born in Jefferson Einstein hospital and graduated from Philadelphia High School for Girls.
May 29, 2024
0
2
Two types of endometriosis-related ovarian cancer arise from the same cells but likely at different stages of the menstrual cycle—a nuance that significantly influences treatment response, reports a recent study led by ...
May 28, 2024
0
36
Conjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, ...
May 28, 2024
0
1
There is a positive association between use of intimate care products, including genital talc, and ovarian cancer, according to a study published online May 15 in the Journal of Clinical Oncology.
May 22, 2024
0
1
Behind the scenes, as tumors progress and gain resistance to treatment, a protein called YB-1 quietly gives directions. Now, researchers at Oregon Health & Science University have developed a first-of-its-kind drug that inhibits ...
May 21, 2024
0
29
Johnson & Johnson announced Wednesday that it would pay out more than $6.5 billion over the next 25 years to settle existing lawsuits claiming that its talc-containing products caused ovarian cancer.
May 2, 2024
0
1
A multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor immune responses in otherwise difficult to treat ...
Apr 30, 2024
0
0
